Maryland Technology Development Corporation - Long COVID Innovation Grant and Loan Program

SB 392 requires Maryland's Technology Development Corporation (MTDC) to create a grant and loan program funding research, product development, and manufacturing for Long COVID treatments. The program establishes the Maryland Long COVID Research Fund (a permanent, nonlapsing fund) and mandates MTDC to contract with an independent scientific review committee to evaluate and recommend funding for proposals. It directly affects public and private entities in Maryland conducting Long COVID research, requiring them to meet criteria set by MTDC for review and oversight. The bill defines Long COVID using the National Academy of Sciences' 2024 standard and ensures funds support treatment innovation through structured application and progress reviews.